4//SEC Filing
Smith Brendan 4
Accession 0001209191-22-046714
CIK 0001674416other
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 5:39 PM ET
Size
9.5 KB
Accession
0001209191-22-046714
Insider Transaction Report
Form 4
Smith Brendan
Chief Financial Officer
Transactions
- Award
Restricted Stock Units
2022-08-16+10,000→ 10,000 total→ Common Shares (10,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of CRSP Common Shares.
- [F2]The restricted stock units shall vest in full on February 16, 2025, subject to continued service to the Company or any of its subsidiaries.
Issuer
CRISPR Therapeutics AG
CIK 0001674416
Entity typeother
Related Parties
1- filerCIK 0001857492
Filing Metadata
- Form type
- 4
- Filed
- Aug 17, 8:00 PM ET
- Accepted
- Aug 18, 5:39 PM ET
- Size
- 9.5 KB